PCRX
Pacira BioSciences, Inc.
24.60$
-0.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.6% | -7.8% | +6.5% | -5.3% | +11.1% | -9.8% | +7.2% | -0.9% | +9.7% | -9.9% | +8.5% | – | |
| – | +20.0% | -0.6% | -6.7% | -12.2% | +2.6% | -14.0% | +19.1% | -16.1% | +17.6% | -9.6% | +21.3% | – | |
| – | +7.6% | -10.4% | +11.7% | -3.0% | +13.6% | -8.7% | +4.2% | +3.6% | +7.8% | -10.0% | +5.2% | – | |
| – | -6.6% | -6.3% | +11.5% | -6.1% | +25.1% | +6.0% | +11.3% | -7.9% | +44.2% | -25.0% | +7.7% | – | |
| – | +1.3% | +8.4% | -10.8% | +7.1% | -6.0% | +6.6% | +20.5% | -11.4% | +20.0% | -10.6% | +156.6% | – | |
| – | -5.7% | +6.1% | -0.9% | +155.1% | -54.4% | +8.1% | -0.7% | +5.4% | +10.4% | -11.1% | +5.6% | – | |
| – | +87.2% | -60.2% | +113.7% | -594.1% | – | -91.9% | +327.1% | -25.1% | -49.8% | +44.9% | -7.7% | – | |
| – | -2.2% | -2.1% | -5.9% | +50.2% | -18.2% | +19.5% | +2.5% | -22.2% | -7.7% | -5.8% | +14.0% | – | |
| – | +103.1% | -59.5% | +168.2% | -479.6% | – | -65.9% | -122.1% | – | -94.0% | +775.3% | -48.9% | – | |
| – | +54.1% | -47.3% | +279.7% | -74.0% | +105.7% | -58.9% | -25.0% | +40.1% | -126.1% | – | -200.8% | – | |
| – | +129.0% | -63.9% | +110.3% | -859.6% | – | -70.0% | -200.7% | – | -69.9% | +78.1% | +59.6% | – | |
| – | +45.2% | -36.8% | +68.8% | -295.9% | – | -33.6% | -13.0% | +17.5% | -26.4% | +16.7% | -13.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.